Blog

“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border.  Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law.  In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”

http://latino.foxnews.com/latino/news/2013/02/01/us-stem-cell-company-heads-to-mexico-after-fda-reprimand/